Grifols, member of CataloniaBio & HealthTech, announced that Raimon Grifols and Víctor Grifols Deu decided to conclude their executive roles and will step down from their positions as Chief Corporate Officer (CCO) and Chief Operating Officer (COO) respectively. Both will remain on the board of directors as non-executive directors. Thomas Glanzmann will continue as Executive Chairman, and Nacho Abia will be appointed as the company's new CEO.
Grifols, which has led numerous innovations for decades, is now setting a new standard of corporate governance for family-owned companies listed on the stock exchange in Spain with this milestone.
Thomas Glanzmann, Executive Chairman, states: "I want to express my deepest gratitude and esteem to Raimon and Víctor, not only for their leadership and valuable contribution to the company's growth but also for their courageous decision to clearly separate ownership and management of the company, a principle also supported by the Board of Directors. The deep family values that have made this company an exceptional enterprise for 115 years will always remain the hallmark of Grifols. The Board also welcomes the new CEO, Nacho Abia, who brings the professional experience, skills, and operational track record necessary to continue driving Grifols to new heights."
Nacho Abia comments: "Taking the reins of Grifols, a global, leading, admired, recognized company with enormous growth potential, is a unique opportunity for me. I am very excited to be part of this reference organization in the healthcare world and to help continue achieving ambitious goals."
Raimon Grifols and Víctor Grifols Deu highlight: "Both as co-CEOs and in our current positions, we are very proud to have been able to contribute to building a world-class organization that has exceptional talent which will continue to strengthen in the coming years to drive business growth and excellence in innovation."
Comments